Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

  1. García-Molina, P.
  2. Sola-Leyva, A.
  3. Luque-Navarro, P.M.
  4. Laso, A.
  5. Ríos-Marco, P.
  6. Ríos, A.
  7. Lanari, D.
  8. Torretta, A.
  9. Parisini, E.
  10. López-Cara, L.C.
  11. Marco, C.
  12. Carrasco-Jiménez, M.P.
Aldizkaria:
Pharmaceutics

ISSN: 1999-4923

Argitalpen urtea: 2022

Alea: 14

Zenbakia: 2

Mota: Artikulua

DOI: 10.3390/PHARMACEUTICS14020426 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus